Author name: Lucid Group

Lucid Group has acquired the leading consulting firm, Synetic Life Sciences. The combined capabilities of Lucid and Synetic represents a unique value proposition for the industry, providing clients with an end-to-end partnership across the development and commercialisation journey, delivering transformative solutions across clients’ organisational needs and brand opportunities. It is a significant step forward for Lucid

We at Lucid are pioneers, transforming the world of healthcare communications, shaping the industry and helping our clients to reach more patients and realise the potential of their medicines. We believe strongly that a successful organisation starts by enabling every single person to be their whole selves, no matter who they love. But none of

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off. . Buckland points out that pandemic storms have changed the atmospherics of product launches, which now fire off at all angles and timings – like a box of fireworks introduced to a stray

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines today.  With a rapidly changing clinical, economic and regulatory environment, the launch of new products has catapulted the pharmaceutical industry into greater complexity and pressure

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.  Why is raising awareness of rare diseases so important? Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on this day to call for more equitable access to social opportunity, treatment and support for people living with a rare disease, their families and carers.  In support